BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: García-Cortés M, Ortega-Alonso A, Lucena MI, Andrade RJ; Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM).l. Drug-induced liver injury: a safety review. Expert Opin Drug Saf 2018;17:795-804. [PMID: 30059261 DOI: 10.1080/14740338.2018.1505861] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Raschi E, De Ponti F. Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors. Front Pharmacol 2019;10:1235. [PMID: 31708776 DOI: 10.3389/fphar.2019.01235] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
2 Danan G, Teschke R. Roussel Uclaf Causality Assessment Method for Drug-Induced Liver Injury: Present and Future. Front Pharmacol. 2019;10:853. [PMID: 31417407 DOI: 10.3389/fphar.2019.00853] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
3 Song Y, Jia MX, Yang G, Feng XY, Yin DH, Kang JB, Zhao Q, Duan JJ. Association of CYP2C19 and UGT1A4 polymorphisms with voriconazole-induced liver injury. Per Med 2020;17:15-22. [PMID: 31797717 DOI: 10.2217/pme-2019-0042] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
4 Liu W, Zeng X, Liu Y, Liu J, Li C, Chen L, Chen H, Ouyang D. The Immunological Mechanisms and Immune-Based Biomarkers of Drug-Induced Liver Injury. Front Pharmacol 2021;12:723940. [PMID: 34721020 DOI: 10.3389/fphar.2021.723940] [Reference Citation Analysis]
5 Jian M, Yang XF, Zhou S, Pi YY, Lei XY. Etiology, diagnosis, and treatment of drug induced liver injury. Shijie Huaren Xiaohua Zazhi 2019; 27(11): 715-720 [DOI: 10.11569/wcjd.v27.i11.715] [Reference Citation Analysis]
6 Wang Z, Xu G, Zhan X, Liu Y, Gao Y, Chen N, Guo Y, Li R, He T, Song X, Niu M, Wang J, Bai Z, Xiao X. Carbamazepine promotes specific stimuli-induced NLRP3 inflammasome activation and causes idiosyncratic liver injury in mice. Arch Toxicol 2019;93:3585-99. [PMID: 31677073 DOI: 10.1007/s00204-019-02606-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 He Q, Shen J, Guan X, Han Y, Jiang X, Shen X, Huang X, Chen Y, Lei C, Xiao X, Lin W. A Zr‐Based MOF with N‐heterocycle and its pH‐controlled drug release behavior. Zeitschrift anorg allge chemie 2022;648. [DOI: 10.1002/zaac.202100248] [Reference Citation Analysis]
8 Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP. Drug-induced liver injury. Nat Rev Dis Primers 2019;5:58. [PMID: 31439850 DOI: 10.1038/s41572-019-0105-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 78] [Article Influence: 27.0] [Reference Citation Analysis]
9 Lugoboni F, Mirijello A, Morbioli L, Faccini M, Casari R, De Cosmo S, Gasbarrini A, Addolorato G. Zolpidem high-dose abuse: what about the liver? Results from a series of 107 patients. Expert Opinion on Drug Safety 2019;18:753-8. [DOI: 10.1080/14740338.2019.1628216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
10 Chierici M, Francescatto M, Bussola N, Jurman G, Furlanello C. Predictability of drug-induced liver injury by machine learning. Biol Direct 2020;15:3. [PMID: 32054490 DOI: 10.1186/s13062-020-0259-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
11 Villanueva-Paz M, Morán L, López-Alcántara N, Freixo C, Andrade RJ, Lucena MI, Cubero FJ. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants (Basel) 2021;10:390. [PMID: 33807700 DOI: 10.3390/antiox10030390] [Reference Citation Analysis]
12 Jiang T, Rong P, Wang W. Chemical probes for drug-induced liver injury imaging. Future Med Chem 2020;12:835-52. [PMID: 32107934 DOI: 10.4155/fmc-2019-0330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
13 Chopyk DM, Grakoui A. Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders. Gastroenterology 2020;159:849-63. [PMID: 32569766 DOI: 10.1053/j.gastro.2020.04.077] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
14 Pineda Salgado L, Gupta R, Jan M, Turkoglu O, Estilo A, George V, Rahman MI. Using an Automated Algorithm to Identify Potential Drug-Induced Liver Injury Cases in a Pharmacovigilance Database. Adv Ther 2021;38:4709-21. [PMID: 34319549 DOI: 10.1007/s12325-021-01856-x] [Reference Citation Analysis]
15 Adeluwa T, McGregor BA, Guo K, Hur J. Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors. Front Pharmacol 2021;12:648805. [PMID: 34483896 DOI: 10.3389/fphar.2021.648805] [Reference Citation Analysis]
16 Hu X, Huang D, Lin C, Li X, Lu F, Wei W, Yu Z, Liao H, Huang F, Huang X, Jia F. Zolpidem improves patients' sleep quality after surgical treatment for infective endocarditis: a prospective observational study. Sleep Breath 2021. [PMID: 34449017 DOI: 10.1007/s11325-021-02479-w] [Reference Citation Analysis]
17 Sun Y, Gu J, Liu R, Zhou H, Lu L, Dai X, Qian X. IL‐2/IL‐6 ratio correlates with liver function and recovery in acute liver injury patients. APMIS 2019;127:468-74. [DOI: 10.1111/apm.12944] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]